IRadimed Corporation – NASDAQ:IRMD
Founder-led company
IRadimed stock price today
$70
+15.32
+28.04%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 9 hours
IRadimed stock price monthly change
+20.52%
month
IRadimed stock price quarterly change
+20.52%
quarter
IRadimed stock price yearly change
+16.29%
year
IRadimed key metrics
Market Cap | 683.09M |
Enterprise value | 641.39M |
P/E | 37.18 |
EV/Sales | 8.99 |
EV/EBITDA | 28.16 |
Price/Sales | 9.71 |
Price/Book | 8.30 |
PEG ratio | -15.06 |
EPS | 1.42 |
Revenue | 67.68M |
EBITDA | 21.19M |
Income | 17.92M |
Revenue Q/Q | 13.71% |
Revenue Y/Y | 19.86% |
Profit margin | 26.12% |
Oper. margin | 29.91% |
Gross margin | 77.14% |
EBIT margin | 29.91% |
EBITDA margin | 31.31% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIRadimed stock price history
IRadimed stock forecast
IRadimed financial statements
| Jun 2023 | 16.13M | 4.17M | 25.91% |
|---|---|---|---|
| Sep 2023 | 16.50M | 5.06M | 30.7% |
| Dec 2023 | 17.45M | 4.53M | 26.01% |
| Mar 2024 | 17.59M | 4.13M | 23.51% |
| 2025 | 81.17M | 20.85M | 25.69% |
|---|---|---|---|
| 2026 | 98.90M | 27.39M | 27.7% |
Analysts Price target
Financials & Ratios estimates
Paying a dividend greater than earnings.
0.82%
Yield TTM
| Payout ratio | 134.21% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | |
| 2022 | 3.53% |
| 2023 | 2.21% |
| Jun 2023 | 81431031 | 12.43M | 15.27% |
|---|---|---|---|
| Sep 2023 | 87406096 | 12.83M | 14.69% |
| Dec 2023 | 92156098 | 20.73M | 22.5% |
| Mar 2024 | 88014180 | 11.89M | 13.51% |
| Jun 2023 | 3.51M | -378.31K | -89.76K |
|---|---|---|---|
| Sep 2023 | 1.39M | -439.02K | -31.37K |
| Dec 2023 | 3.91M | -632.81K | -262.59K |
| Mar 2024 | 3.88M | -478.80K | -8.03M |
IRadimed alternative data
| Aug 2023 | 123 |
|---|---|
| Sep 2023 | 123 |
| Oct 2023 | 123 |
| Nov 2023 | 123 |
| Dec 2023 | 123 |
| Jan 2024 | 123 |
| Feb 2024 | 123 |
| Mar 2024 | 148 |
| Apr 2024 | 148 |
| May 2024 | 148 |
| Jun 2024 | 148 |
| Jul 2024 | 148 |
IRadimed other data
22.64%
-21.19%
of IRMD is owned by hedge funds
59
-18
2.86M
-2.67M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 0 | 1947 |
| Nov 2024 | 0 | 2690 |
| Dec 2024 | 0 | 2500 |
| Patent |
|---|
Grant Filling date: 18 Mar 2020 Issue date: 5 Apr 2022 |
Grant Filling date: 22 Dec 2017 Issue date: 8 Mar 2022 |
Application Filling date: 25 Jun 2021 Issue date: 21 Oct 2021 |
Grant Utility: Liquid infusion apparatus Filling date: 2 Nov 2020 Issue date: 29 Jun 2021 |
Application Filling date: 2 Nov 2020 Issue date: 11 Mar 2021 |
Grant Utility: Liquid infusion apparatus Filling date: 24 Jan 2018 Issue date: 3 Nov 2020 |
Application Filling date: 18 Mar 2020 Issue date: 10 Sep 2020 |
Grant Filling date: 4 Jan 2018 Issue date: 14 Apr 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 8 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 3 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Pivoting Away From The Fabulous 7: Small Cap Picks For A 2024 Rotation
IRadimed Continues Ploughing Along With Superb Economic Characteristics
IRadimed: Revise To Buy With Exceptional Incremental ROIC In Q4
IRadimed Q4: A Bottom-Line Beat, A Special Cash Dividend, Maintain Buy
iRadimed: Reduce To Hold, Price Visibility Around $28 More Certain
IRadimed: Reduce Equity Beta With Upside Capture
-
What's the price of IRadimed stock today?
One share of IRadimed stock can currently be purchased for approximately $70.
-
When is IRadimed's next earnings date?
Unfortunately, IRadimed's (IRMD) next earnings date is currently unknown.
-
Does IRadimed pay dividends?
Yes, IRadimed pays dividends and its trailing 12-month yield is 0.82% with 134% payout ratio.It means that the company is paying a dividend greater than earnings. The last IRadimed stock dividend of undefined was paid on 26 Sep 2025.
-
How much money does IRadimed make?
IRadimed has a market capitalization of 683.09M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 23% to 65.56M US dollars.
-
What is IRadimed's stock symbol?
IRadimed Corporation is traded on the NASDAQ under the ticker symbol "IRMD".
-
What is IRadimed's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of IRadimed?
Shares of IRadimed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are IRadimed's key executives?
IRadimed's management team includes the following people:
- Mr. Roger E. Susi Founder, Chairman, Chief Executive Officer & Pres(age: 72, pay: $434,900)
- Mr. Christopher K. Scott Chief Operating Officer, Chief Financial Officer & Sec.(age: 55, pay: $340,260)
-
Is IRadimed founder-led company?
Yes, IRadimed is a company led by its founder Mr. Roger E. Susi.
-
How many employees does IRadimed have?
As Jul 2024, IRadimed employs 148 workers.
-
When IRadimed went public?
IRadimed Corporation is publicly traded company for more then 11 years since IPO on 16 Jul 2014.
-
What is IRadimed's official website?
The official website for IRadimed is iradimed.com.
-
Where are IRadimed's headquarters?
IRadimed is headquartered at 1025 Willa Springs Drive, Winter Springs, FL.
-
How can i contact IRadimed?
IRadimed's mailing address is 1025 Willa Springs Drive, Winter Springs, FL and company can be reached via phone at +40 76778022.
IRadimed company profile:
IRadimed Corporation
iradimed.comExchange:
NASDAQ
Full time employees:
148
Industry:
Medical - Devices
Sector:
Healthcare
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
1025 Willa Springs Drive
Winter Springs, FL 32708
Winter Springs, FL 32708
CIK: 0001325618
ISIN: US46266A1097
CUSIP: 46266A109
